Leung WK et al. |
Effect of peroxisome proliferator activated receptor gamma ligands on growth and gene expression profiles of gastric cancer cells. |
2004 |
Gut |
pmid:14960510
|
Yuan Z et al. |
Cardioprotective effects of peroxisome proliferator activated receptor gamma activators on acute myocarditis: anti-inflammatory actions associated with nuclear factor kappaB blockade. |
2005 |
Heart |
pmid:15774612
|
Galli A et al. |
Peroxisome proliferator-activated receptor gamma transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells. |
2000 |
Hepatology |
pmid:10613734
|
Copple IM et al. |
The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system. |
2008 |
Hepatology |
pmid:18785192
|
Kuboki S et al. |
Peroxisome proliferator-activated receptor-gamma protects against hepatic ischemia/reperfusion injury in mice. |
2008 |
Hepatology |
pmid:18085707
|
Mendez M and LaPointe MC |
PPARgamma inhibition of cyclooxygenase-2, PGE2 synthase, and inducible nitric oxide synthase in cardiac myocytes. |
2003 |
Hypertension |
pmid:12885795
|
Katsumata Y et al. |
Endogenous prostaglandin D2 and its metabolites protect the heart against ischemia-reperfusion injury by activating Nrf2. |
2014 |
Hypertension |
pmid:24101662
|
Ikeda U et al. |
Peroxisome proliferator-activated receptor-gamma ligands inhibit nitric oxide synthesis in vascular smooth muscle cells. |
2000 |
Hypertension |
pmid:10856269
|
Kim HY and Kim HS |
Upregulation of MIP-2 (CXCL2) expression by 15-deoxy-Delta(12,14)-prostaglandin J(2) in mouse peritoneal macrophages. |
2007 |
Immunol. Cell Biol. |
pmid:17130903
|
Imaizumi T et al. |
15-Deoxy-D12,14-prostaglandin J2 inhibits CX3CL1/fractalkine expression in human endothelial cells. |
2002 |
Immunol. Cell Biol. |
pmid:12406386
|
Kim HY et al. |
Upregulation of LPS-induced chemokine KC expression by 15-deoxy-delta12,14-prostaglandin J2 in mouse peritoneal macrophages. |
2005 |
Immunol. Cell Biol. |
pmid:15877607
|
Harris SG and Phipps RP |
Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. |
2002 |
Immunology |
pmid:11849312
|
Sykes L et al. |
The CRTH2 agonist Pyl A prevents lipopolysaccharide-induced fetal death but induces preterm labour. |
2013 |
Immunology |
pmid:23374103
|
Han S and Sidell N |
Peroxisome-proliferator-activated-receptor gamma (PPARgamma) independent induction of CD36 in THP-1 monocytes by retinoic acid. |
2002 |
Immunology |
pmid:11972632
|
Arnold R et al. |
Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. |
2007 |
Immunology |
pmid:17425601
|
Miyawaki T et al. |
Combination of midazolam and a cyclooxygenase-2 inhibitor inhibits lipopolysaccharide-induced interleukin-6 production in human peripheral blood mononuclear cells. |
2012 |
Immunopharmacol Immunotoxicol |
pmid:21854184
|
Sánchez-Gómez FJ et al. |
Modulation of GSTP1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs. |
2013 |
Inflamm Allergy Drug Targets |
pmid:23596995
|
MartÃnez AE et al. |
15-Deoxy-Δ(12,14)-prostaglandin J2 exerts pro- and anti-inflammatory effects in mesangial cells in a concentration-dependent manner. |
2012 |
Inflamm Allergy Drug Targets |
pmid:22309084
|
Fernandez-Bustamante A et al. |
Early increase in alveolar macrophage prostaglandin 15d-PGJ2 precedes neutrophil recruitment into lungs of cytokine-insufflated rats. |
2013 |
Inflammation |
pmid:23616184
|
Hashimoto K et al. |
Peroxisome proliferator-activated receptor gamma ligand inhibits cell growth and invasion of human pancreatic cancer cells. |
2002 |
Int J Gastrointest Cancer |
pmid:12630765
|
Fujita M et al. |
Cytotoxicity of 15-deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent pathway and the involvement of the JNK and Akt pathway in renal cell carcinoma. |
2012 |
Int J Med Sci |
pmid:22991494
|
Abbasi S et al. |
Elimination of the biphasic pharmacodynamics of 15d-PGJ2 by controlling its release from a nanoemulsion. |
2016 |
Int J Nanomedicine |
pmid:27354798
|
Ueki S et al. |
Anti- and proinflammatory effects of 15-deoxy-delta-prostaglandin J2(15d-PGJ2) on human eosinophil functions. |
2007 |
Int. Arch. Allergy Immunol. |
pmid:17541271
|
Chiba T et al. |
15-Deoxy-Delta(12,14)-prostaglandin J2 induces IL-8 and GM-CSF in a human airway epithelial cell line (NCI-H292). |
2009 |
Int. Arch. Allergy Immunol. |
pmid:19494510
|
Imaizumi T et al. |
15-deoxy-delta(12,14)-prostaglandin J2 inhibits IFN-gamma-induced galectin-9 expression in cultured human umbilical vein endothelial cells. |
2003 |
Int. Arch. Allergy Immunol. |
pmid:12759491
|
Zhang M et al. |
Curcumin inhibits trinitrobenzene sulphonic acid-induced colitis in rats by activation of peroxisome proliferator-activated receptor gamma. |
2006 |
Int. Immunopharmacol. |
pmid:16782535
|
Napimoga MH et al. |
Low doses of 15d-PGJ2 induce osteoblast activity in a PPAR-gamma independent manner. |
2013 |
Int. Immunopharmacol. |
pmid:23597428
|
Kanunfre CC et al. |
Ciglitizone and 15d PGJ2 induce apoptosis in Jurkat and Raji cells. |
2004 |
Int. Immunopharmacol. |
pmid:15251113
|
Wu P et al. |
Inflammation pro-resolving potential of 3,4-dihydroxyacetophenone through 15-deoxy-delta12,14-prostaglandin J2 in murine macrophages. |
2007 |
Int. Immunopharmacol. |
pmid:17761349
|
Chou YH et al. |
The possible role of heat shock factor-1 in the negative regulation of heme oxygenase-1. |
2005 |
Int. J. Biochem. Cell Biol. |
pmid:15618017
|
Yu JH et al. |
SOCS 3 and PPAR-gamma ligands inhibit the expression of IL-6 and TGF-beta1 by regulating JAK2/STAT3 signaling in pancreas. |
2008 |
Int. J. Biochem. Cell Biol. |
pmid:18035585
|
Winnett G et al. |
Prostaglandin J2 metabolites inhibit aromatase activity by redox-sensitive mechanisms: potential implications for breast cancer therapy. |
2003 |
Int. J. Cancer |
pmid:12494466
|
Badawi AF and Badr MZ |
Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma and levels of prostaglandin E2 and 15-deoxy-delta12,14-prostaglandin J2 in human breast cancer and metastasis. |
2003 |
Int. J. Cancer |
pmid:12455057
|
Koyani CN et al. |
15-deoxy-Δ¹²,¹â´-PGJâ‚‚ promotes inflammation and apoptosis in cardiomyocytes via the DP2/MAPK/TNFα axis. |
2014 |
Int. J. Cardiol. |
pmid:24698234
|
Tsujimoto S et al. |
Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ. |
2016 |
Int. J. Mol. Med. |
pmid:27431935
|
Li H and Narahara H |
15-Deoxy-Δ(12,14)-prostaglandin J(2) induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer cell lines. |
2013 |
Int. J. Mol. Med. |
pmid:23403520
|
Da Silva Morais A et al. |
Peroxisome proliferated-activated receptor gamma ligand, Pioglitazone, does not prevent hepatic fibrosis in mice. |
2007 |
Int. J. Mol. Med. |
pmid:17143554
|
Jung WK et al. |
The 15-deoxy-δ12,14-prostaglandin J2 inhibits LPS‑stimulated inflammation via enhancement of the platelet‑activating factor acetylhydrolase activity in human retinal pigment epithelial cells. |
2014 |
Int. J. Mol. Med. |
pmid:24337644
|
Yoshimura R et al. |
The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells. |
2003 |
Int. J. Mol. Med. |
pmid:14612958
|
Okano H et al. |
The PPARgamma ligand, 15-Deoxy-Delta12,14-PGJ2, regulates apoptosis-related protein expression in cholangio cell carcinoma cells. |
2003 |
Int. J. Mol. Med. |
pmid:14612959
|
Moriai M et al. |
Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells. |
2009 |
Int. J. Oncol. |
pmid:19360348
|
Haslmayer P et al. |
The peroxisome proliferator-activated receptor gamma ligand 15-deoxy-Delta12,14-prostaglandin J2 induces vascular endothelial growth factor in the hormone-independent prostate cancer cell line PC 3 and the urinary bladder carcinoma cell line 5637. |
2002 |
Int. J. Oncol. |
pmid:12239635
|
Matsuzaki Y et al. |
15-deoxy-Delta12, 14-prostaglandin J2 activates the expression of p15INK4b gene, a cyclin-dependent kinase inhibitor. |
2005 |
Int. J. Oncol. |
pmid:16010433
|
Morosetti R et al. |
The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines. |
2004 |
Int. J. Oncol. |
pmid:15254749
|
Shim J et al. |
The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells. |
2010 |
Int. J. Oncol. |
pmid:19956851
|
Cekanova M et al. |
Gene alterations by peroxisome proliferator-activated receptor gamma agonists in human colorectal cancer cells. |
2008 |
Int. J. Oncol. |
pmid:18360708
|
Takashima T et al. |
PPAR-gamma ligands inhibit growth of human esophageal adenocarcinoma cells through induction of apoptosis, cell cycle arrest and reduction of ornithine decarboxylase activity. |
2001 |
Int. J. Oncol. |
pmid:11494023
|
Marshall JC |
Modeling MODS: what can be learned from animal models of the multiple-organ dysfunction syndrome? |
2005 |
Intensive Care Med |
pmid:15782317
|
Hauser B et al. |
Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. |
2006 |
Intensive Care Med |
pmid:16534570
|
Marzocco S et al. |
The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock. |
2005 |
Intensive Care Med |
pmid:15868139
|